| Date | Time | Source | |
| 05/22/2013 | 5:53PM | DJN | MARKET SNAPSHOT: U.S. Stocks Drop On Fed Tapering Worries
By Polya Lesova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks slid Wednesday, reversing gains after minutes from the Federal Reserve's latest meeting and comments from the Fed chief suggested the central bank may begin tapering its bond-buying program in coming months. Stocks had a wild ride during... More...>> |
| 05/22/2013 | 5:25PM | ZACKS | Gilead's Sofosbuvir under European Review - Analyst Blog
Gilead Sciences Inc. (GILD) recently announced that its Marketing Authorisation Application (MAA) for HCV candidate sofosbuvir (formerly GS-7977), submitted to the European Medicines Agency (EMA) on Apr 17, 2013, has been validated and is under review. Gilead is looking to get the candidate approved in combination with... More...>> |
| 05/22/2013 | 5:00PM | DJN | MARKET SNAPSHOT: U.S. Stocks Drop On Fed Tapering Worries
By Polya Lesova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks slid Wednesday, reversing gains after minutes from the Federal Reserve's latest meeting and comments from the Fed chief suggested the central bank may begin tapering its bond-buying program in coming months. Stocks had a wild ride during... More...>> |
| 05/22/2013 | 3:49PM | DJN | MARKET SNAPSHOT: U.S. Stocks Drop On Fed Tapering Worries
By Polya Lesova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks extended losses on Wednesday after minutes from the Federal Reserve latest meeting and comments from the Fed chief suggested the central bank may begin tapering its bond-buying program in coming months. Stocks had a wild ride during... More...>> |
| 05/22/2013 | 3:06PM | DJN | MARKET SNAPSHOT: U.S. Stocks Drop On Fed Tapering Worries
By Polya Lesova and Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks fell on Wednesday, erasing earlier strong gains after minutes from the Federal Reserve latest meeting and comments from the Fed chief suggested the central bank may begin tapering its bond-buying program in coming months. Stocks had... More...>> |
| 05/22/2013 | 2:42PM | DJN | Bristol-Myers Shares Jump as Analyst Hails New Cancer Treatment Drug
By Russ Britt Shares of Bristol-Myers Squibb Co. (BMY) jumped more than 6% Wednesday after Citigroup (C) raised its rating on the company's shares to buy from neutral, as an analyst at the brokerage says the drug maker is helping to bring about "the beginning of the end for cancer." Bristol-Myers was recently up $2.55... More...>> |
| 05/22/2013 | 12:59PM | DJN | MARKET SNAPSHOT: U.S. Stocks Hold Gains After Bernanke Bond Talk
By Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks showed solid gains in early-afternoon action Wednesday, recovering a little from a dip on Federal Reserve Chairman Ben Bernanke saying tapering of the central bank's bond buying could occur in the "next few meetings." The Dow Jones Industrial Average... More...>> |
| 05/16/2013 | 4:30PM | BW | Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock
Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has notified the New York Stock Exchange (“NYSE”) of its intention to voluntarily delist its $2 Convertible Preferred Stock (the “Preferred Stock”) from the NYSE. The company’s decision to delist the Preferred Stock was driven by the low number... More...>> |
| 05/15/2013 | 6:30PM | DJN | Pair of Studies Show Power of Immune System to Fight Cancer
By Ron Winslow Positive results from two early-stage studies of drugs from Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY) provided fresh evidence that the power of the immune system is emerging as a promising new weapon against cancer. In the Bristol-Myers study, giving two drugs that target the immune system... More...>> |
| 05/15/2013 | 6:10PM | BW | Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 7 p.m. EDT (6 p.m. CDT) on Sunday, June 2, 2013, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus... More...>> |
| 05/15/2013 | 6:00PM | BW | Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Cl...
Bristol-Myers Squibb Company (NYSE: BMY) today announced that new data on its approved and investigational immuno-oncology compounds, Yervoy and the investigational PD-1 receptor blocking antibody nivolumab, will be featured in six oral presentations at the 49th Annual Meeting of the American Society of Clinical Oncology... More...>> |
| 05/15/2013 | 12:30PM | ZACKS | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog
The Medicines Company (MDCO) recently gained US Food and Drug Administration (FDA) approval for the use of Recothrom in pediatric patients. The FDA expanded Recothrom’s label following the completion of a phase IV open-label, single-group safety and immunogenicity study. Recothrom, a recombinant thrombin, is a topical... More...>> |
| 05/14/2013 | 3:18PM | BW | Bristol-Myers Squibb to Present at UBS Global Health Care Conference
Bristol-Myers Squibb Company (NYSE: BMY) will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City. Charles Bancroft, executive vice president and chief financial officer, will make a formal presentation about the company at 8:30 a.m. EDT. Investors and the general public are invited... More...>> |
| 05/14/2013 | 12:50PM | ZACKS | Amgen to Set Up JV in China - Analyst Blog
Amgen (AMGN) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd. The JV will focus on the commercialization of Amgen’s colorectal cancer drug, Vectibix, in China. While Zhejiang Beta Pharma will hold a 51% stake in the JV, Amgen-Beta Pharmaceuticals Co... More...>> |
| 05/10/2013 | 8:00AM | ZACKS | Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog
Simcere Pharmaceutical Group (SCR) reported first quarter 2013 earnings of 9 cents per American Depositary Share (ADS) beating the Zacks Consensus Estimate by a penny. We note that each ADS represents two ordinary shares of Simcere Pharma. Revenues at Simcere Pharma came in at $85.1 million in the first quarter of 2013... More...>> |
| 05/08/2013 | 10:30AM | BW | Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
Bristol-Myers Squibb Company (NYSE: BMY) will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas. Giovanni Caforio, president, U.S. Pharmaceuticals, will make a formal presentation about the company at 10 a.m. PDT (1 p.m. EDT). Investors and the general public are invited... More...>> |
| 05/07/2013 | 1:04PM | BW | Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this subanalysis showed that the reductions in stroke or systemic... More...>> |
| 05/06/2013 | 5:00PM | BW | Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this subanalysis showed that the reductions in stroke or systemic... More...>> |
| 05/06/2013 | 11:40AM | ZACKS | Good News for Bristol-Myers - Analyst Blog
Bristol-Myers Squibb Company (BMY) recently received positive news from the US Food and Drug Administration (FDA) when the US regulatory authority approved the pharma major’s HIV drug Sustiva for treating children between three months and three years. The body weight of the children should not exceed 3.5 kilograms... More...>> |
| 05/06/2013 | 9:22AM | DJN | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Monday's session are Arkansas Best Corp. (ABFS), Tyson Foods Inc. (TSN) and Apollo Global Management LLC (APO). Transportation company Arkansas Best said its largest subsidiary, ABF Freight System Inc., reached a tentative agreement on a five-year labor contract... More...>> |
